September 21st, 2014
Parkinson’s Drug Recall
Parkinson’s Drug Recall
September 4, 2014
Nearly 4,000 bottles of a Parkinson’s combination drug are being pulled from shelves, according to the U.S. Food and Drug Administration.
The U.S. nationwide recall is due to what may potentially be ‘superpotent’ carbidopa/levodopatablets.
This recall comes on the heels of a recall in April and June for the Israeli generic drug maker.
References:
1. Teva Recalling ‘Superpotent’ Drug for Parkinson’s Disease. FDANews. 2014 Aug 27.
2. Palmer E. Teva recalls Parkinson's disease drug because it may be 'superpotent'. Fierce Pharma. 2014 Aug 26.
PLN Topics:
Medication Errors
RELATED ARTICLES
Baxter Recalls Potassium Chloride Injection
Heparin Recall Due to Human Hair
Warfarin Sodium Tablets Recall
FDA Issues Reminder to Avoid Products from Texas Compounder
Compounding Pharmacy Recall
- August 12th, 2012
Discontinuation of Statin Therapy Due to Muscular Side EffectsRead - June 15th, 2015
Levodopa Better First Parkinson's Drug than MAO Inhibitors or Dopamine AgonistsRead - August 15th, 2012
Azithromycin & Levofloxacin May Increase The Risk of Cardiovascular DeathRead - October 7th, 2012
CDC: Meningitis Outbreak Spreads to 7 StatesRead - August 14th, 2015
Diagnosing Headache: Patient, Provider Communication is KeyRead
Geriatric Nutrition
Without good nutrition, positive drug therapy outcomes are very difficult to obtain, For the best in Geriatric Nutritional Information
Find out more Optima SolutionsContinuing Education
Each month we will post an analysis of specific aspects of government long-term healthcare regulations.
Find out moreHealth care alerts
Video
